Literature DB >> 15897355

Inflammation and cardiovascular disease in patients with diabetes: lessons from the Diabetes Control and Complications Trial.

Andreas Festa, Steven M Haffner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15897355     DOI： 10.1161/01.CIR.0000167558.77793.E8

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

1.  Type 2 diabetes and cardiovascular diseases: do they share a common soil? The Asian Indian experience.

Authors:  Rajendra Pradeepa; Adamsha Nazir; Viswanathan Mohan
Journal:  Heart Asia       Date:  2012-01-01

2.  Uric acid and inflammatory markers.

Authors:  Carmelinda Ruggiero; Antonio Cherubini; Alessandro Ble; Angelo J G Bos; Marcello Maggio; Vishwa D Dixit; Fulvio Lauretani; Stefania Bandinelli; Umberto Senin; Luigi Ferrucci
Journal:  Eur Heart J       Date:  2006-04-12       Impact factor: 29.983

3.  Thymoquinone Attenuates Cardiomyopathy in Streptozotocin-Treated Diabetic Rats.

Authors:  Mustafa S Atta; Ali H El-Far; Foad A Farrag; Mohamed M Abdel-Daim; Soad K Al Jaouni; Shaker A Mousa
Journal:  Oxid Med Cell Longev       Date:  2018-10-30       Impact factor: 6.543

4.  Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes.

Authors:  Gareth S D Purvis; Fausto Chiazza; Jianmin Chen; Rodrigo Azevedo-Loiola; Lukas Martin; Dennis H M Kusters; Chris Reutelingsperger; Nikolaos Fountoulakis; Luigi Gnudi; Muhammed M Yaqoob; Massimo Collino; Christoph Thiemermann; Egle Solito
Journal:  Diabetologia       Date:  2017-10-30       Impact factor: 10.122

5.  The Prediction of Cardiac Events in Patients with Acute ST Segment Elevation Myocardial Infarction: A Meta-analysis of Serum Uric Acid.

Authors:  Hailong Wang; Jianjun Yang; Jiang Sao; Jianming Zhang; Xiaohua Pang
Journal:  Open Life Sci       Date:  2018-11-09       Impact factor: 0.938

Review 6.  Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes.

Authors:  Ping Yang; Jian Feng; Qing Peng; Xing Liu; Zhongcai Fan
Journal:  Oxid Med Cell Longev       Date:  2019-12-06       Impact factor: 6.543
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.